Novartis announced it will spend $23 billion to construct and expand facilities in the United States. The planned investment includes six new manufacturing plants, including two radioligand therapy ...

Bengaluru, India–based Biocon Biologics announced today that bevacizumab-nwgd (Jobevne), a biosimilar of bevacizumab (Avastin; Genentech), was approved by the FDA. Bevacizumab, which is given ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

1Biomarkers and Clonal Dynamics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license ...

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama. 2Division of Pediatric Hematology/Oncology, University of Alabama at Birmingham, Birmingham, ...

1Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 2Department of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research ...

*Corresponding Author: Ravi Bhatia, Division of Hematology/Oncology, Department of Medicine, The University of Alabama at Birmingham, 1802 6th Avenue, South, North Pavilion, Room 2555C, Birmingham, AL ...

1Genome Research Center, GC Genome, Yongin-si, South Korea. *Corresponding Author: Eun-Hae Cho, Genome Research Center, GC Genome, 107, Ihyeon-ro 30 beon-gil, Yongin-si, 16924, South Korea. E-mail: ...

Copyright held by the owner/author(s).

Copyright held by the owner/author(s).